BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10789731)

  • 1. Tubal ligation and risk of breast cancer.
    Brinton LA; Gammon MD; Coates RJ; Hoover RN
    Br J Cancer; 2000 May; 82(9):1600-4. PubMed ID: 10789731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubal ligation and the risk of ovarian carcinoma.
    Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
    Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubal sterilization and risk of cancer of the endometrium.
    Lacey JV; Brinton LA; Mortel R; Berman ML; Wilbanks GD; Twiggs LB; Barrett RJ
    Gynecol Oncol; 2000 Dec; 79(3):482-4. PubMed ID: 11104624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Rosenblatt KA; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of paternal age at birth and the risk of breast cancer in offspring: a case control study.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Yoo KY; Kang D
    BMC Cancer; 2005 Oct; 5():143. PubMed ID: 16259637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
    Knight JA; Lesosky M; Blackmore KM; Voigt LF; Holt VL; Bernstein L; Marchbanks PA; Burkman RT; Daling JR; Whittemore AS
    Breast Cancer Res Treat; 2008 May; 109(1):157-64. PubMed ID: 17616808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women.
    Shu XO; Jin F; Dai Q; Wen W; Potter JD; Kushi LH; Ruan Z; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):483-8. PubMed ID: 11352858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive factors and breast cancer risk among older women.
    Shantakumar S; Terry MB; Teitelbaum SL; Britton JA; Millikan RC; Moorman PG; Neugut AI; Gammon MD
    Breast Cancer Res Treat; 2007 May; 102(3):365-74. PubMed ID: 17033925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime physical activity and the risk of breast cancer: a case-control study.
    Kruk J
    Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
    Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.